Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$2.01 – $3.06
52% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $60.6M | $84.1M | $99.4M | $103.1M | $119.7M | $167.5M | $170.0M | $198.9M |
| Cost of revenue | $15.4M | $21.5M | $28.3M | $26.9M | $33.6M | $41.9M | $37.6M | $43.3M |
| Gross profit | $45.2M | $62.6M | $71.1M | $74.9M | $86.2M | $125.7M | $132.4M | $155.7M |
| Gross margin | 74.6% | 74.4% | 71.5% | 72.7% | 72.0% | 75.0% | 77.9% | 78.2% |
| R&D | $9.9M | $11.4M | $15.6M | $17.2M | $22.4M | $29.5M | $32.8M | $34.7M |
| Operating income | $4.4M | $15.5M | $11.7M | $10.8M | $1.8M | $19.6M | $9.1M | $8.9M |
| EBITDA | $7.1M | $15.5M | $16.7M | $15.7M | $7.9M | $29.5M | $21.7M | $31.8M |
| Net income | $5.8M | $13.6M | $10.1M | $8.6M | $3.7M | $19.9M | $13.0M | $20.7M |
| Net margin | 9.5% | 16.2% | 10.2% | 8.3% | 3.1% | 11.9% | 7.6% | 10.4% |
| EPS (diluted) | 0.02 | 0.04 | 0.03 | 0.03 | 0.01 | 0.06 | 0.04 | 0.07 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $215M | $0.06 | $0.05–$0.06 | 1 |
| 2027 | $242M | $0.09 | $0.08–$0.09 | 1 |
| 2028 | $279M | $0.13 | $0.12–$0.14 | 1 |
| 2029 | $276M | $0.12 | $0.12–$0.13 | 1 |
Forward consensus · source: Financial Modeling Prep
NANOSONICS LTD ORD
No one on the platform currently holds NNCSF.
No tracked institution reports a position in NNCSF as of their last filing.
No one on the platform has traded NNCSF yet.
| $185M |
| — |
| SAFLFSafilo Group S.p.A. | $2.01 | +0.00% | $790M | — |
| SAFLYSafilo Group S.p.A. | $3.76 | +0.00% | $1.1B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 30.1× earnings vs its 49.5× historical median P/E.
Fair value ≈ $4.20 · price $2.55 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.